公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Management of Toxicities of Targeted Therapies | CHIH-HSIN YANG ; CHIA-CHI LIN ; CHIA-YU CHU | IASLC Thoracic Oncology | 4 | 0 | |
2016 | Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer | SHAO-LUN LU ; Feng-Ming Hsu ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHIA-HSIEN CHENG | Case Reports in Oncology | 2 | 0 | |
2016 | The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients | SHANG-GIN WU ; Liu Y.-N.; Tsai M.-F.; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; CHIH-HSIN YANG ; Wen Y.-F.; JIN-YUAN SHIH | Oncotarget | 207 | 191 | |
2013 | MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib | Huang M.-H.; JIH-HSIANG LEE ; Chang Y.-J.; Tsai H.-H.; Lin Y.-L.; Lin A.M.Y.; CHIH-HSIN YANG | Molecular Oncology | 71 | 63 | |
2007 | Melatonin attenuates arsenite-induced apoptosis in rat brain: Involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of α-synuclein | Lin A.M.Y; Fang S.F; Chao P.L; CHIH-HSIN YANG | Journal of Pineal Research | 76 | 70 | |
2009 | Melatonin inhibits arsenite-induced peripheral neurotoxicity | Lin A.M.Y; Feng S.F; Chao P.L; CHIH-HSIN YANG | Journal of Pineal Research | 25 | 24 | |
2007 | MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib | Bean J.; Brennan C.; JIN-YUAN SHIH ; Riely G.; Viale A.; Wang L.; Chitale D.; Motoi N.; Szoke J.; Broderick S.; Balak M.; Chang W.-C.; CHONG-JEN YU ; Gazdar A.; Pass H.; Rusch V.; Gerald W.; Huang S.-F.; PAN-CHYR YANG ; Miller V.; Ladanyi M.; CHIH-HSIN YANG ; Pao W. | Proceedings of the National Academy of Sciences of the United States of America | 1513 | 1379 | |
2016 | Meta-Analysis of First-Line Pemetrexed Plus Platinum Treatment in Compared to Other Platinum-Based Doublet Regimens in Elderly East Asian Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer | Lu S; Cheng Y; Zhou C.-C; Wang J; Chih-Hsin CHIH-HSIN YANG ; Zhang P.-H; Zhang X.-Q; Wang X; Orlando M; Wu Y.-L. | Clinical Lung Cancer | 10 | | |
2017 | Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial | Thress K.S; Jacobs V; Angell H.K; CHIH-HSIN YANG ; Sequist L.V; Blackhall F; Su W.-C; Schuler M; Wolf J; Gold K.A; Cantarini M; Barrett J.C; Jänne P.A. | Journal of Thoracic Oncology | 19 | 19 | |
2015 | Monotherapy Administration of Sorafenib in Patients with Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens | Paz-Ares L; Hirsh V; Zhang L; De Marinis F; CHIH-HSIN YANG ; Wakelee H.A; Seto T; Wu Y.-L; Novello S; Juhász E; Arén O; Sun Y; Schmelter T; Ong T.J; Penã C; Smit E.F; Mok T.S. | Journal of Thoracic Oncology | 98 | 88 | |
2013 | Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy | TZU-HSIU TSAI ; CHING-YAO YANG ; CHAO-CHI HO ; WEI-YU LIAO ; I-SHIOW JAN ; KUAN-YU CHEN ; JANN-YUAN WANG ; SHENG-YUAN RUAN ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Lung Cancer | 33 | 30 | |
1994 | Multidrug Resistance-associated Protein Gene Overexpression and Reduced Drug Sensitivity of Topoisomerase II in a Human Breast Carcinoma MCF7 Cell Line Selected for Etoposide Resistance | Schneider E; Horton J.K; CHIH-HSIN YANG ; Nakagawa M; Cowan K.H. | Cancer Research | 270 | 270 | |
2007 | Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma | CHIA-CHI LIN ; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIUN HSU ; YU-CHIEH TSAI ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HUNG HSU | Anti-Cancer Drugs | 10 | 8 | |
1997 | MVP (mitomycin-C, vinblastine, cisplatin) salvage chemotherapy for relapsed and refractory metastatic breast cancer | CHIUN HSU ; KUN-HUEI YEH ; RUEY-LONG HONG ; CHIH-HSIN YANG ; Lin M.-T.; YAO-CHANG CHEN ; ANN-LII CHENG | Journal of the Formosan Medical Association | 4 | 3 | |
2009 | National Center of Excellence for Clinical Trials and Research at National Taiwan University Hospital | CHIA-CHI LIN ; CHIH-HSIN YANG ; ANN-LII CHENG ; Chan W.-K.; HONG-NERNG HO | Drug Information Journal | 3 | 2 | |
2022 | Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: Results of a phase 2, single-arm, open-label study | Tan, Daniel S W; Kim, Sang-We; Ponce Aix, Santiago; Sequist, Lecia V; Smit, Egbert F; CHIH-HSIN YANG ; Hida, Toyoaki; Toyozawa, Ryo; Felip, Enriqueta; Wolf, Juergen; Grohé, Christian; Leighl, Natasha B; Riely, Gregory; Cui, Xiaoming; Zou, Mike; Ghebremariam, Samson; O'Sullivan-Djentuh, Leslie; Belli, Riccardo; Giovannini, Monica; Kim, Dong-Wan | European journal of cancer (Oxford, England : 1990) | 4 | 4 | |
2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | WEI-YU LIAO ; Chen J.-H.; Wu M.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU | Clinical Lung Cancer | 22 | 20 | |
2017 | New data on clinical decisions in NSCLC patients with uncommon EGFR mutations | Wu T.; Hsiue E.H.; JIH-HSIANG LEE ; Chia-Chi Lin ; CHIH-HSIN YANG | Expert Review of Respiratory Medicine | 15 | 14 | |
2020 | Nivolumab safety and efficacy in advanced, platinum-resistant, non-small cell lung cancer, radical radiotherapy-ineligible patients: A phase II study in Taiwan | Chen Y.-M.; CHIH-HSIN YANG ; Su W.-C.; Chong I.-W.; Hsia T.-C.; Lin M.-C.; Chang G.-C.; Chiu C.-H.; CHAO-CHI HO ; Wu S.-Y.; Hung J.-Y.; Wang C.-C.; Yang T.-Y.; CHONG-JEN YU | Journal of the Formosan Medical Association | 8 | 5 | |
2012 | Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma | Girard N; Sima C.S; Jackman D.M; Sequist L.V; Chen H; CHIH-HSIN YANG ; Ji H; Waltman B; Rosell R; Taron M; Zakowski M.F; Ladanyi M; Riely G; Pao W. | European Respiratory Journal | 75 | 90 | |